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1 Introduction 
Affinity chromatography is a specific type of liquid chromatography in 
which the separation mechanism is based on an interaction between an 
immobilized and biologically related binding agent with an applied an-
alyte [1–3]. This method is closely tied to supramolecular interactions 
in that it makes use of the selective and reversible interactions that oc-
cur in many complexes that are formed in biological systems, or mimics 
of such systems. Examples of biological supramolecular interactions are 
those that take place between antibodies with their antigens, enzymes 
with their substrates or inhibitors, and hormones with their receptors 
[1–8]. Advantages of using these interactions in affinity chromatogra-
phy include the high selectivity, strong binding, and good resolution that 
are made possible in this method for specific target compounds [5–8]. 
The stationary phase in affinity chromatography, which makes up the 
immobilized component of the supramolecular complex, is often called 
the “affinity ligand.” The support that contains this stationary phase is 
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packed or placed into a column and used to selectively retain the com-
plementary target to the affinity ligand, where this target represents the 
second part of the supramolecular complex [5–7]. 
The most common format in which immobilized ligands and columns 
are used in affinity chromatography is the on/off elution mode, as shown 
in Figure 1 [5, 9]. In this format and in the presence of an application 
buffer, a sample mixture containing the target analyte is applied to the 
column. Non-retained components pass through the column and are 
Figure 1 A typical sample application and elution scheme used in affinity chromatog-
raphy, the on–off elution mode.   
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quickly eluted, while the target interacts with the immobilized affinity li-
gand. To obtain and release the captured agent, a separate elution buffer 
is typically used in a situation where the analyte and binding agent have 
strong interactions, such as occurs for systems with association equilib-
rium column regeneration. This situation is possible when the supramo-
lecular interactions that are involved in retention have an association 
equilibrium constant that is less than approximately 105 or 106 M−1 [1, 7, 
9–11]. constants of 106 M−1 or higher [1, 7–9]. To weaken these interac-
tions, the elution buffer may have a change from the application buffer in 
its pH, polarity, or ionic strength; this approach is known as “non-specific 
elution”. Alternatively, the elution buffer may contain a competing agent 
to promote analyte elution by mass action, giving a method referred to 
as “biospecific elution” [5, 9]. After the analyte has been released, the 
column may then be regenerated by reapplying the original application 
buffer or some similar solution [5, 9]. The system is then ready for the 
next sample to be processed. In weak affinity chromatography (WAC), 
the same mobile phase is used for both sample application and elution 
under isocratic conditions, as well as for  
Affinity chromatography has been popular for decades as a tool for 
the selective purification of biological molecules [1–7]. In addition, this 
technique has been used as a method for sample preparation during 
chemical or biochemical analysis and as a tool for the isolation, measure-
ment, or characterization of targets in biological, clinical, and environ-
mental samples [1–6, 12–16]. This review will discuss recent develop-
ments in affinity chromatography and related supramolecular separation 
methods. Topics that will be discussed will include advances with regard 
to the types of supports, biological binding agents, and immobilization 
methods that are employed in this method. New developments in the 
applications of affinity chromatography will also be examined. 
2 Supports for Affinity Chromatography 
Many materials and matrices have been utilized as supports in affinity 
chromatography. These supports can be divided into three main catego-
ries (see Table 1) [1–3, 17, 18]. The first category is natural supports, 
such as agarose, dextran, and cellulose. The second group is inorganic 
matrices, such as silica or glass. The third group is made up of synthetic 
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materials that can be used as chromatographic supports, such as poly-
styrene or polyacrylamide [1, 17, 18]. 
2.1 Natural Supports and Related Materials 
Agarose is the most popular support material used in affinity chromatog-
raphy for both the large- and small-scale purification of targets [3, 19–
23]. This was also the material used in the first modern separations that 
were described for affinity chromatography in 1968 [3, 8, 19–21]. Aga-
rose has a large pore size, which makes it suitable for many biomedical 
separations or the immobilization of large biomolecules. The low cost, 
low non-specific binding of this material for many biological agents, and 
good stability of agarose over a broad pH range also make agarose ap-
pealing as a support for many applications of affinity chromatography 
[20, 21]. However, the relatively low mechanical stability of agarose at 
high operating pressures does limit its use as a support in analytical-
scale separations based on high-performance liquid chromatography 
[3, 5, 21]. Recently, a microporous membrane emulsification technique 
has been used to develop monodisperse microspheres based on agarose 
[24]. Beaded agarose in the form of microspheres with selected diame-
ters and porosity is commercially available under the tradename Sepha-
rose [3, 21, 25]. The hydroxyl groups of agarose can be partially or fully 
derivatized, and several functional groups can be incorporated into this 
support, such as amine, carboxyl, cyano, or sulfonate groups [21, 26–28]. 
Cellulose is another natural material that has been used as a support 
in affinity chromatography, specifically for the purification of antibodies 
or enzymes [3, 20, 29]. Currently, cellulose is not as popular as agarose 
Table 1 Types of Supports Used in Affinity Chromatography 
General Type of Support  Examples of Supports 
Natural  Agarose, cellulose, dextran, agarose-chitosan composites 
Inorganic  Silica, aluminum oxide, titania 
Synthetic  Polystyrenes, polyacrylamides, polysulfones, polyamides, 
cryogels 
Miscellaneous  Magnetic beads and particles (e.g., based on iron oxides) 
Smart materials (e.g., thermoresponsive polymers) 
Nanomaterials (e.g., multi-walled and single-walled  
carbon nanotubes)    
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as a support for affinity chromatography due to its lower surface area 
and lower mechanical stability [3, 20]. However, cellulose in a mem-
brane format can provide low backpressures and be used in prepara-
tive work at high flow rates [3, 30, 31]. Adsorptive cellulosic fibers have 
been emerging as new support matrices for affinity chromatography due 
to their high swelling capacity and good mechanical strength [32–34]. 
Besides agarose and cellulose, dextran-based matrices such as Sep-
hadex, Superdex, and Sephacryl are also widely used in bioaffinity chro-
matography [30, 35]. Supports for which strong one-point interactions 
with target proteins are required can be modified with dextran [36, 37]. 
In affinity chromatography this can be an advantage because multipoint 
interactions with other proteins can lead to nonspecific adsorption. 
Carbohydrate-based hybrid supports with a dense core (e.g., quartz) 
have been used to prepare expanded-bed adsorbents for affinity separa-
tions [38–41]. Agarose [38–40] and cellulose [41] have often been em-
ployed for developing these hybrid supports. The use of expanded-bed 
adsorbents helps to avoid column clogging by solid contaminants by al-
lowing the creation of a fluidized or expanded bed during sample ap-
plication [3, 20, 21, 23]. Expanded-bed adsorbents have been utilized 
in such applications as protein purification [42] and isolation of mono-
clonal antibodies [43, 44]. 
2.2 Inorganic Supports 
Inorganic materials such as porous silica particles and glass beads, both 
modified with hydrophilic groups, are commonly used in high-perfor-
mance affinity chromatography (HPAC) [3, 5, 20, 21]. These inorganic 
supports have the advantages of being available in various pore sizes and 
particle diameters and show good mechanical strength at the pressures 
and flow rates that are used in high-performance liquid chromatography 
(HPLC) [3, 5, 20, 45]. Non-modified inorganic supports do have some 
disadvantages when compared to many carbohydrate supports, includ-
ing their lower pH range stability and the possible presence of higher 
non-specific binding [3, 20]. However, these materials can be modified 
and used with a wide range of affinity ligands, and they are compatible 
with target purification or analysis in applications that span from phar-
maceutical and biomedical analysis to flow-based immunoassays [3, 20, 
22, 45–47]. For instance, HPLC-grade silica has been used as a support to 
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prepare lectin affinity microcolumns to examine binding by drugs with 
structural variants of alpha1-acid glycoprotein (AGP) [48]. In another 
report, rapid protein purification was obtained by using a surface-im-
printed silica support [49]. 
Monolithic silica supports have also been receiving attention in af-
finity chromatography [50–52]. There are several advantages of mono-
liths over traditional particulate supports, including their availability 
in a range of sizes and shapes [21, 50]. Other advantages of monolithic 
supports consist of their low backpressures, high permeability, and good 
separation efficiencies [21, 50]. In one report, a hybrid organic-silica af-
finity monolith support was made using “thiolene” click chemistry to im-
mobilize an aptamer that was then applied to recognize a trace protein 
[53]. WAC has been increasingly applied to study interactions in biolog-
ical systems [54, 55]. In one recent study, silica-based monolith nano-
columns were made using a small amount of targeted protein and used 
in WAC coupled with mass spectrometry for rapid fragment screening, 
as may be used in the future as a tool for drug discovery [56]. 
Other inorganic-based supports have been considered for use in affin-
ity columns. An example of one such material is titania, or TiO2 [57–62]. 
Supports that contain titania have been employed in a method known 
as metal oxide affinity chromatography, or MOAC, to bind and capture 
targets such as phosphopeptides [57–60]. In addition, dendritic poly-
glycerol-coated chitosan nanomaterials that contained Ti4+ and titania 
nanoparticles have been utilized for the isolation and separation of gly-
copeptides and phosphopeptides [61, 62]. 
2.3 Synthetic Supports 
Synthetic polymers such as polystyrene and polymethacrylate have also 
been used as supports for both traditional and high-performance appli-
cations of affinity chromatography [3, 21, 30]. Polystyrene supports have 
been used as a perfusion media and in other separation formats in af-
finity chromatography [21, 63, 64]. The long hydrophobic backbone of 
polystyrene can lead to high levels of non-specific interactions with bio-
logical molecules like proteins, but this can be addressed by coating a hy-
drophilic layer on this material [21, 63, 64]. Polymethacrylates are more 
hydrophilic in nature and can be used either in their original or mod-
ified forms for affinity separations [46, 50]. Other synthetic polymers 
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such as polysulfones and polyamides are also used in affinity chroma-
tography as membrane supports [65]. These organic polymers are of-
ten stable over a broad pH range, which is appealing for their use in af-
finity separations [3, 21, 46]. 
Organic polymers, agarose, and cryogels are also gaining attention 
as monolithic supports in affinity chromatography [21, 50, 52, 66–77]. 
Polymeric monolithic supports based on glycidyl methacrylate (GMA) 
and ethylene glycol dimethacrylate (EDMA) have been used with immo-
bilized agents such as antibodies, enzymes, proteins, and peptides [52, 
66–69]. For instance, polymethacrylate monoliths known as  convec-
tive interaction media (CIM), have been used in a wide range of appli-
cations ranging from the purification of large biological agents such as 
viruses, proteins, and DNA to antibody-based separations and immobi-
lized metal ion affinity chromatography (IMAC) [51, 70–74]. The large 
pore sizes of cryogels have made these materials useful in the separa-
tion or capture of large analytes such as eukaryotic cells and bacteria 
[76, 77]. The low surface area seen in cryogels has been noted to lead 
to a possible decrease in ligand density and binding capacity [75]. How-
ever, this limitation can be overcome by using small binding agents (e.g., 
metal ion chelates), surface grafting of the ligand, or embedding func-
tionalized particles within a cryogel [78–80]. 
2.4 Magnetic Beads and Particles 
Magnetic particles such as magnetic beads and nanoparticles have been 
used in some studies as supports for affinity chromatography [81–84]. 
Magnetic beads are often prepared by depositing magnetic iron oxides 
(i.e., Fe3O4) into porous mono-sized polymer particles, although poly-
mers containing colloidal magnetite or other magnetic metals such as 
cobalt and manganese have been used as well. Binding agents can be at-
tached to these particles by placing reactive functional groups such as 
isocyanate, vinyl, and epoxy residues on the polymers [81–84]. 
The use of magnetic beads or particles with immobilized binding 
agents was described as early as 1977 when agarose-polyacrylate beads 
containing magnetic cores were prepared and used in a sandwich im-
munoassay with an enzyme label [81, 83]. Several other types of mag-
netic beads that could be used with affinity ligands were developed af-
ter this, including materials made from starch, carbohydrate, cellulose, 
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or dextran and containing iron oxide; magnetic beads were also pre-
pared from iron oxide and polymers such as acrylates, methacrylates, 
or styrene [81, 83, 85]. The use and performance of these initial forms 
of these beads in a magnetic field suffered from variability in the beads’ 
sizes and levels of magnetism [81, 83]. These limitations were later over-
come with the preparation of magnetic beads with more uniform sizes 
(e.g., spherical monodisperse particles with sizes in the range of 0.5 to 
100 μm) [83]. 
Magnetic particles have been used as supports in several affinity sep-
arations [86–95]. These materials have been used to bind targets such as 
antibodies or other proteins, antigens, and DNA or RNA [86–94]. For in-
stance, magnetic poly(2-hydroxyethylmethacrylate) beads were used to 
isolate lysozyme from aqueous solutions and egg white and cytochrome 
c from an aqueous sample [84, 88]. Magnetic attapulgite, containing bo-
ronic acid as a binding agent, was used as a support for the selective en-
richment of several nucleosides from urine samples [90]. Trace ginsen-
osides were separated from rat plasma by using magnetic nanoparticles 
and a boronate as the binding agent [93]. The dye Cibacron Blue 3GA was 
coupled to magnetic support made of Fe3O4 particles entrapped by poly-
vinyl alcohol and used for the purification of lysozyme and alcohol dehy-
drogenases from clarified yeast homogenates [94]. Magnetic nanoparti-
cles containing Fe3O4 were used for the extraction of luteolin from honey 
samples using boronic acid as the affinity ligand [96].  
2.5 Smart Materials 
A number of smart materials have been explored for use in affinity chro-
matography. Smart materials, or stimuli-responsive intelligent materials, 
are polymers which respond to external chemical, physical, or biochemical 
factors [97–99]. These polymers change their structure or function (e.g., 
an alteration in their shape, phase, or ability to take part in molecular rec-
ognition) as they respond to changes in factors such as temperature, ionic 
strength, solvent concentration, UV radiation, magnetic fields, pH, or the 
presence of a given binding agent or type of ion. These polymers are then 
able to return to their initial state once the source of the external stimu-
lus has been removed or reversed [97–99]. Stimuli-responsive polymers 
can also be either mixed physically or conjugated with a biomolecule to 
form materials for affinity-related applications [99–101]. 
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The smart materials that are most often used in affinity chromatogra-
phy are those that respond to a temperature change (i.e., thermorespon-
sive polymers) [100–103]. These polymers show temperature-depen-
dent hydrophobic/hydrophilic variations and conformational changes in 
their polymer chains in response to variations in the surrounding tem-
perature [100–104]. Examples of common thermoresponsive polymers 
that have been used in bioseparations are poly-(N-isopropylacrylamide), 
poly(vinyl) ether, oligo(ethylene glycol) methacrylate, and related deriv-
atives [102, 104–107]. Among these, oligo(ethylene glycol) has been of 
particular interest [100– 107]. An application mentioned in Section 2.4 
was the use of boronic acid on oligo(ethylene glycol)-based magnetic 
nanoparticles as thermoresponsive supports for the extraction of lute-
olin from honey [96]. A support for the capture and release of lysozyme 
from human urine was described that made use of oligo(ethylene glycol) 
and a methacrylate-based molecularly imprinted polymer [108]. Bovine 
serum albumin (BSA) was purified from protein mixtures and samples 
by using a thermal- and salt-sensitive molecularly imprinted polymer 
(MIP) as the support [109]. 
2.6 Nanomaterials 
Nanomaterials have yet to be widely examined for use as affinity ligands 
[110]. However, there have been reports of using nanomaterials to de-
velop stationary phases that can be used in some chiral separations [111–
113]. Carbon nanotubes have been shown to have some chiral recogni-
tion [114]. Both multi-walled and single-walled carbon nanotubes have 
been embedded in monoliths and used to separate enantiomers of vari-
ous organic small molecules [115, 116]. For instance, an organic monolith 
containing multi-walled carbon nanotubes was used to separate the en-
antiomers of bupivacaine, dansyl-methionine, dansyl-phenylalanine, and 
2,4-dichlorophenoxypropionic acid [115]. A monolith containing single-
walled carbon nanotubes was used in chiral separations for sulconazole, 
nomifenzine, etozoline, chlorpheniramine, and celiprolol [116]. 
2.7 Support Formats 
Several forms of support have been utilized in affinity chromatography 
[3, 20, 21]. The majority of reports on this method have used packed 
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columns for either  low-to-medium performance affinity chromatog-
raphy (e.g., using agarose or cellulose) or HPAC (e.g., based on silica or 
glass beads) have used packed columns [3, 21, 30]. Small volume col-
umns, including short length or small internal diameter columns, have 
also been of interest in recent years [3, 117–119]. Over the past decade, 
monoliths and perfusion-based media have both gained popularity in 
analytical and preparative applications of affinity chromatography [3, 
21]. Expanded or fluidized beds have also become popular for prepara-
tive uses of affinity chromatography [3, 20, 21]. 
Several types of supports (e.g., capillaries, packed beds, and mono-
liths) have been considered for use in microchips and miniaturized de-
vices for affinity-based separations and methods [21, 120–126]. The ad-
vantages of using these supports for affinity chromatography are that 
they require a smaller amount of binding agent than more traditional-
sized columns and consume less mobile phase. They also usually require 
smaller sample injection volumes and can often provide a short analy-
sis time [120, 126]. 
Packed capillaries in these methods usually have an internal diameter 
of 75–500 μm and a length of 5–15 cm [120, 127–129]. They are typically 
used at low flow rates (i.e., nL/min to μL/min) and are often employed 
with nano-HPLC or microbore HPLC systems [120, 127–129]. Capillary 
columns with IMAC-based stationary phases have been used in the pu-
rification and biointeraction studies of several proteins [127, 128]. For 
example, Ti4+ complexed on monodisperse-porous silica microspheres 
was used in a capillary column for the purification of phosphoproteins 
from milk and human serum [128]. Monolithic capillary columns con-
taining Cu2+ were employed for the isolation of immunoglobulin G (IgG), 
transferrin, and albumin from human plasma [127]. A microfluidic af-
finity capillary microcolumn was made that contained a MIP formed by 
the interaction of a cis-diol containing-template, β-nicotinamide ade-
nine nucleotide, and the functional monomer, 4-vinylphenylborononic 
acid; this boronic acid monolith was then employed for the purification 
of β-nicotinamide adenine nucleotide [129]. Packed capillaries as af-
finity columns have also been employed for studying the interaction of 
drugs with serum proteins and identification of ligands specific to the 
adenosine A2A receptor [120, 130]. 
Short affinity microcolumns having a length of 5–50 mm and a typ-
ical internal diameter of 2.1 mm have also been employed in several 
Wo o l f o r k  e t  a l .  i n  A dva n c e s  in  C h ro m ato g ra p h y  5 8  ( 2 0 2 1 )       12
studies [48, 131–142]. These microcolumns usually have low back-
pressures, which allows their use at high flow rates [48, 131–137, 139–
142]. These microcolumns have been used in applications such as stud-
ies of drug interactions with AGP or human serum albumin (HSA) by 
zonal elution, frontal analysis, and ultrafast affinity extraction [48, 
131–137, 139– 142]. These microcolumns have been employed in bio-
interaction studies involving AGP and the lectins concanavalin A (Con 
A) and Aleuria aurantia lectin (AAL) [48] and in work examining bind-
ing by drugs such as tapsin derivatives with epidermal growth factor 
receptors [138]. 
Two other microscale formats that have been used in affinity chro-
matography are microchips and microfluidic flow cells [121, 126, 143, 
144]. For example, a polymer chip that contained TiO2-ZrO2 was em-
ployed for the enrichment of phosphopeptides from a tryptic digest of 
β-casein based on MOAC [143]. Con A was immobilized  on regener-
ated bacterial cellulose in a microchip and was used for the separation 
of lysozyme from transferrin [144]. Microfluidic frontal affinity chro-
matography based on Ste2-G-protein-coupled receptor on a gold sub-
strate held in a flow cell was used to study the interaction of this re-
ceptor with α-factor, a natural pheromone peptide [121]. Biotin–avidin 
interactions in a flow cell have been exploited for the detection of HIV-
1, based on dual labeling of amplification products specific to the HIV-1 
gene by using biotin and fluorescent tags and passing these products 
through streptavidin agarose beads [145]. 
3 Immobilization Methods 
The choice of immobilization technique for preparing affinity columns 
is an important factor to consider. Figure 2 shows several immobiliza-
tion techniques that can be used when preparing affinity columns. It is 
essential that the correct immobilization scheme is selected for a par-
ticular application because several effects that can result from immobi-
lization schemes can alter the actual or apparent activity of an immobi-
lized binding agent [1, 146–148]. These factors include steric hindrance, 
multisite attachment, and improper orientation of the affinity ligand [3, 
147, 148]. 
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3.1 Non-Covalent Immobilization 
Non-covalent immobilization techniques based upon the physical ad-
sorption of affinity ligands to chromatographic the supports were em-
ployed initially. In this approach, depending on the properties of sup-
ports and affinity ligands, physical adsorption of the binding agent to the 
support may occur through electrostatic interactions, hydrophobic in-
teractions, or hydrogen bonding [44, 148]. Both natural supports (e.g., 
agarose and cellulose) and inorganic supports (e.g., alumina and silica) 
have been used for non-covalent immobilization [149, 150]. This ap-
proach is simple [3, 149] but suffers from the possibility of limited sta-
bility of the resulting affinity support and the loss of binding agent ac-
tivity through random orientation [149]. 
Figure 2 General types of immobilization schemes used in affinity chromatography.   
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Non-covalent immobilization can also be obtained through biospe-
cific adsorption. In this approach, a secondary ligand is attached to a 
support that can then bind and immobilize the primary affinity ligand 
[3, 151]. The most common examples of such an approach are to use 
biotin as a tag on a binding agent that is then allowed to bind to a sup-
port that contains avidin or streptavidin [149, 152, 153]. Another pop-
ular example of biospecific adsorption is the use of protein A or protein 
G (i.e., immunoglobulin- binding proteins) on supports to bind and im-
mobilize antibodies [154–156]. 
Entrapment or encapsulation is another form of non-covalent im-
mobilization. This approach makes use of the physical encapsulation 
or trapping of an affinity ligand within the pores of a support or within 
a cross-linked support or polymer network [157]. Enzymes, proteins, 
and other affinity ligands have been entrapped for a number of years 
within silicate-based sol-gels [157–159]. Another pathway for entrap-
ment is the use of a cross-linking agent to immobilize an affinity ligand 
onto a support [3, 131, 160–162]. Hydrazide-activated silica supports 
combined with oxidized glycogen as a capping agent have been used 
to entrap HSA, AGP, IgG, and other agents [131, 160, 162–164]. This 
latter method was also used with an online immunoextraction/entrap-
ment system to extract and place a serum protein (i.e., HSA and modi-
fied forms of this protein) within small affinity columns for use in drug-
binding studies [163]. 
Another immobilization method that has seen much interest in re-
cent years is one that is based on boronic acids [165–170]. This ap-
proach makes use of the interaction of a boronic acid with the vicinal 
diol groups in many carbohydrate groups to generate boronate esters. 
To accomplish this, the surface of the support should first be modified 
with boronic acid derivatives such as aminophenylboronic acid [166–
170]. Although this technique avoids the need to carry out prior modi-
fication of the carbohydrate groups, the reaction of diol groups with bo-
ronic acids is usually reversible at a physiological pH [165, 171, 172]. 
In addition, there may be competition between different classes of gly-
coproteins or carbohydrate-containing agents for immobilization onto 
this type of support [165]. However, such competition can be avoided 
by the formation of aldehydes via glycoengineering and/or enzymatic 
oxidation methods and incorporating unnatural fucose derivatives into 
the carbohydrate moieties [171, 173–176].  
Wo o l f o r k  e t  a l .  i n  A dva n c e s  in  C h ro m ato g ra p h y  5 8  ( 2 0 2 1 )       15
3.2 Covalent Immobilization 
Covalent immobilization is the most widely used method for coupling an 
affinity ligand to a support material [1, 146, 148]. This technique usu-
ally requires that the ligand or support, or both, be activated prior to im-
mobilization. Examples of covalent immobilization methods are the cy-
anogen bromide (CNBr) method, the Schiff base (reductive amination) 
method, and approaches that use activating agents such as carbodiimide 
[146, 148, 177–179]. Many other techniques for this purpose have also 
been described, as reviewed previously [146, 148]. 
The CNBr method is a two-step process which involves an initial mod-
ification of hydroxyl groups on the support to obtain active cyanate es-
ters or imidocarbonate groups; these groups can then undergo a reac-
tion with primary amine groups on affinity ligands to form a covalent 
linkage [146, 148, 180]. Examples of recent applications for this method 
include its use in the activation of a Sepharose 4B support for the immo-
bilization of sulfanilamide and the activation of a cryogel monolith for 
the immobilization of HSA [181, 182]. Although this method remains a 
common technique for the immobilization of affinity ligands to materi-
als like agarose, it does suffer from health and safety issues related to 
the toxicity of its reagents and side-products [18]. 
The Schiff base method involves the use of a support that has been ac-
tivated or converted into a form that contains aldehyde groups or amine 
groups. These groups are then combined with a ligand that has primary 
amine groups or aldehyde groups, respectively, to form a Schiff base. Be-
cause a Schiff base is a reversible bond, this reaction is usually conducted 
in the presence of a mild reducing agent such as sodium cyanoborohy-
dride to create a more stable secondary amine linkage [148]. This immo-
bilization method has been used in a number of recent reports for the 
immobilization of HSA to silica for drug-protein binding studies [132, 
183]. This method has also been employed in the immobilization of anti-
human serum transferrin antibodies, anti-HSA antibodies, and the lec-
tin Con A onto maltose-bonded silica for use in HPAC [184]. 
One example of a carbodiimide activation method is to activate car-
boxylic groups on a support by using a carbodiimide such as 1-ethyl-
3-(3-dimethylaminopropyl) carbodiimide (EDC) in the presence of 
N-hydroxysuccinimide (NHS) [185]. The result of this process is a sta-
ble-but-reactive NHS ester. The activated NHS ester groups can then be 
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reacted directly with primary amine groups on an affinity ligand such 
as a protein or peptide through amide bond formation [185]. The car-
bodiimide activation method has been used recently for the immobili-
zation of gelatin onto a poly(hydroxyethyl methacrylate) cryogel and 
peptides onto agarose supports [186, 187]. The carbodiimide activa-
tion technique has also been used for the immobilization of Con A onto 
silica [188]. Other studies have used NHS-activated supports that have 
been produced without the use of carbodiimides. For example, NHS-ac-
tivated silica has been created by reacting succinic anhydride with ami-
nopropyl silica, and subsequently reacting this product with NHS, as 
well as by combining disuccinimidyl suberate with aminopropyl silica 
[146, 148, 177–179]. 
Multisite attachment and improper orientation remain as challenges 
that are often associated with covalent immobilization through primary 
amine groups and  other relatively common functional groups [148]. 
These challenges can be avoided by employing covalent immobilization 
methods that use more site-selective sites on an affinity ligand, such as 
free sulfhydryl groups [146, 148, 189, 190]. This latter method has been 
used for immobilization of protein A, protein G, and HSA onto supports 
such as agarose beads and silica for affinity-based separations [190–
192]. This approach has also been used to immobilize peptides such as 
glutathione onto agarose for the purification of fusion proteins and pep-
tide-specific antibodies [193, 194]. Although covalent attachment of af-
finity ligands to supports via sulfhydryl groups is attractive as a site-
selective immobilization option, the aggressive conditions required to 
generate the sulfhydryl groups on certain ligands may also result in un-
desired reactions that can alter the binding characteristics of the ligand 
[165, 195–197]. 
For sugars and glycoproteins, including antibodies, improper orien-
tation and multisite attachment effects can be significantly minimized 
by covalent coupling through carbohydrate groups [146, 148, 198–204]. 
In this approach, initial oxidation of the carbohydrate group is first car-
ried out by oxidizing agents like periodate or by an enzymatic reaction to 
form aldehyde groups [148, 199, 203, 205]. Hydrazide or amine groups 
that have been placed on the support can then be reacted with these al-
dehydes to covalently attach the ligand [200–203, 205]. The main chal-
lenge with this approach is that certain important amino acids such as 
histidine, methionine, and tryptophan may be oxidized along with the 
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carbohydrates by periodate, thus altering the site selectivity and bind-
ing properties of the binding agent [195–197]. Therefore, care must be 
taken to use mild oxidation conditions [148]. 
4 Binding Agents Used in Affinity Chromatography 
4.1 Biological Agents as Affinity Ligands 
The first use of a biological binding agent as a stationary phase in af-
finity chromatography can be traced back to 1910 when Starkenstein 
used starch as a support to isolate α-amylase [206]. This type of affin-
ity chromatography is now commonly called bioaffinity chromatogra-
phy [1, 3]. This general method gained popularity for the isolation of 
enzymes and other biological agents following the work in 1968 by Cu-
atrecasas et al., who used columns containing nuclease inhibitors to iso-
late α-chymotrypsin, carboxypeptidase A and staphylococcal nuclease 
[3, 19, 151]. Over the past 50 years, bioaffinity chromatography has re-
mained one of the most common types of affinity chromatography [3, 
18, 22, 30, 151]. Examples of biological agents that can be used as affin-
ity ligands are shown in Table 2. This section will examine the major 
types of affinity ligands that consist of biological agents and new devel-
opments that have taken place with such stationary phases. 
4.1.1 Immunoaffinity Chromatography 
Immunoaffinity chromatography (IAC) is the most common form of bio-
affinity chromatography [207–210]. This method is based on the highly 
specific and strong interactions that often take place between antibodies 
and their target antigens. These interactions are used in IAC to capture, 
isolate, and purify various biochemicals and chemical agents [208–211]. 
The versatility of antibodies with regard to the many types of targets 
against which they can be prepared has made IAC a powerful purifica-
tion method for use in many applications. These applications have in-
cluded sample preparation, sample cleanup, and clinical or diagnostic 
assays for drugs, hormones, toxins, and biomarkers [207–214]. 
Applications of IAC may involve the use of various elution and detec-
tion methods. For example, this approach has been used with pH step 
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elution for the isolation of plasma and serum proteins in biological ma-
trices, as followed by detection based on absorbance measurement or 
tandem mass spectrometry [207–209]. IAC has also been used to isolate 
other agents, such as glycoproteins and carbohydrates [207, 208, 212, 
214]. When used for sample pretreatment, IAC has aided in the isolation 
Table 2 Types of Biological Binding Agents Used in Affinity Chromatography 
Type of Binding  Targets  Examples of Applications  
Agent 
Antibodies and  Complementary antigens or Immunoaffinity chromatography; 
   antigens     antibodies      immunoextraction;     
   immunodepletion;  
     chromatographic immunoassays 
Immunoglobulin- Immunoglobulins, antibodies, Antibody purification and 
   binding proteins     and antibody fragments     analysis; biospecific adsorption 
   (e.g., protein A,      of antibodies  
   protein G, protein L)   
Lectins (e.g., Con A,  Glycoproteins, glycolipids, Lectin affinity chromatography;   
   WGA, AAL)   and polysaccharides     glycan analysis; isolation of  
      carbohydrate-containing targets 
Enzymes  Enzyme substrates and  Purification of enzyme  
    inhibitors     inhibitors; chiral separations;  
     immobilized enzyme reactors 
Serum proteins  Various drugs and low mass Biointeraction studies;  
   (e.g., HSA, BSA,  AGP) hormones     chiral separations 
Biotin  Avidin or streptavidin  Capture or labeling of agents that  
     contain avidin or streptavidin;  
     biospecific adsorption 
Carbohydrates  Targets that bind poly- Chiral separations; 
    saccharides or cyclic     purification of agents that 
    oligosaccharides       bind carbohydrates 
Lipids  Targets that interact with  Immobilized artificial membrane 
    lipids or binding agents     chromatography; immobilized 
    contained within lipid    liposome chromatography; 
    structures        biointeraction studies; screening  
     of compounds that bind to  
     membrane receptors 
Nucleic acids and  Targets that bind to general DNA affinity chromatography;  
   aptamers      or specific structures or     aptamer affinity chromatography;  
    sequences within a nucleic     purification and isolation of DNA 
    acid or aptamer      binding proteins; purification,  
     enrichment or analysis so small  
     targets that bind to aptamers     
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of compounds from water or food samples for further analysis by other 
liquid chromatography (LC) methods, as employed for the determina-
tion of antibiotics and toxins in such matrices [213, 215]. In addition, 
IAC has also been used as the basis for chromatographic immunoassays 
and has been developed using both competitive and non-competitive 
binding formats [213, 216–219]. More details on recent developments 
in these analytical applications are provided in Section 5.  
4.1.2 Immunoglobulin-Binding Proteins 
Immunoglobulin-binding proteins are another important set of biolog-
ical binding agents that are used in bioaffinity chromatography [207, 
220–229]. Two common examples of these agents are proteins A and G 
[221–224, 228, 229]. Protein A is a surface protein found in the cell wall 
of the bacterium Staphylococcus aureus [220]. Protein G is an immuno-
globulin-binding protein from Streptococci bacteria. Both these binding 
agents have a high affinity for the constant, or Fc, region of many types of 
polyclonal or monoclonal antibodies, which makes these useful in the de-
tection and purification of various subclasses of immunoglobulins [207, 
220–223]. Although protein A and G both bind to antibodies from var-
ious species, they differ in their affinity and dependence between spe-
cies and immunoglobulin types [207, 220, 224]. For example, proteins 
A and G both have strong binding to most forms of human IgG-class an-
tibodies [207, 230]. However, proteins A and G differ in their binding to 
human IgM- and IgA-class antibodies [207]. 
Other types of immunoglobulin-binding proteins have been reported 
as well. An example is protein L, which is isolated from the bacterial 
strain Peptostreptococcus magnus [226, 227]. Unlike protein A and pro-
tein G, protein L binds through the light chains instead of the Fc region 
of immunoglobulins. This feature gives protein L an ability to bind to a 
wider range of immunoglobulin classes than proteins A and G (e.g., hu-
man IgA, IgD, IgE, IgG, and IgM) [226, 227]. Recombinant forms and 
mixtures of these immunoglobulin proteins have also been employed 
in affinity methods capture, purify, and measure immunoglobulins in 
samples [207, 220–224, 228, 229, 231]. For example, the adsorption ki-
netics of recombinant human IgG antibodies with protein A was stud-
ied by affinity chromatography [222]. The affinity of protein A for IgG 
from various species was also examined [223]. Protein G affinity chro-
matography was used to determine the amount of soluble IgG in bovine 
colostrum products [224]. 
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4.1.3 Lectins 
The use of lectins as binding agents in chromatography results in a 
method known as lectin affinity chromatography (LAC) [3, 48, 220, 232, 
233]. Lectins are carbohydrate- binding proteins that are highly specific 
for targets that contain complementary sugar groups [220, 232, 233]. 
LAC has frequently been used for the isolation and separation of gly-
coproteins and their glycoforms, as well as glycolipids and polysaccha-
rides, thus making this technique a valuable approach to glycan analy-
sis [48, 232, 233]. For example, this method has been employed for the 
separation and analysis of glycoforms for AGP based on lectin microcol-
umns [48]. 
Many types of lectins have been used in LAC. Two common examples 
are Con A and wheat germ agglutinin (WGA), which can be utilized to 
bind agents containing high-mannose type glycans or N-acetyl-d-glucos-
amine and sialic acids, respectively [220]. Additional lectins that have 
been employed in LAC are jacalin, AAL, various types of Phaseolus vul-
garis agglutinin (PHA), Datura stramonium agglutinin (DSA), Lens culi-
naris agglutinin (LCA), Maackia amurensis lectin (MAM), Ricinus commu-
nis agglutinin (RCA), and Sambucus sieboldiana agglutinin (SSA) [3, 48, 
220]. The coupling of lectin columns for the characterization of glycans 
on the same glycoconjugate is referred to as serial lectin affinity chro-
matography (SLAC) [234]. For example, N-glycosylated and O-glycosyl-
ated proteins have been examined by using a set of lectin columns for 
the determination of glycan structures [233]. 
4.1.4 Enzymes 
Enzymes are another group of biological agents that are often em-
ployed as ligands or targets in affinity chromatography [3, 11, 220]. 
Enzymes can be coupled to various chromatographic supports, includ-
ing silica or monoliths, and through the use of various immobilization 
methods [3, 11, 220]. Enzymes can undergo selective and stable in-
teractions with their substrates and inhibitors, which can make en-
zymes valuable for the purification of enzyme inhibitors as well as for 
scavenging impurities [3, 11, 220, 235–237]. For example, catalase has 
been used for scavenging perborate and hydrogen peroxide, horserad-
ish peroxidase has been employed for the removal of chlorophenols 
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from wastewater, and rhodanese has been utilized for the removal of 
cyanides in effluents and air [220, 236, 237]. Enzyme-inhibitor inter-
actions have further been exploited for the purification of enzyme in-
hibitors, such as the use of trypsin to isolate trypsin inhibitor, and DD-
peptidase to bind penicillin [220]. Trypsin has recently been entrapped 
in a sol-gel monolithic column as a means to screen for N-α-benzoyl-dl-
arginine-4-nitroanilide hydrochloride [235]. Enzyme inhibitors have 
also been extensively used for the purification of enzymes, as will be 
discussed later in Section 5 [3, 11, 220]. 
Other applications of enzymes have involved their use in solid-phase 
extraction (SPE) and immobilized enzyme reactors (IMERs) for the 
screening of bioactive compounds from natural products [22, 238–242]. 
In such work based on IMERs, a substrate that is specific for the immobi-
lized enzyme is introduced along with an extract of the natural product 
to be examined [22, 239–242]. The immobilized enzyme is then used to 
catalyze the formation of a product from the substrate and to see how 
this process is affected by bioactive compounds in the natural product 
extract (e.g., through competitive or non-competitive binding with the 
enzyme to prevent the formation of the product) [22, 239–242]. En-
zymes such as acetylcholinesterase, gelatinase, xanthine oxidase, and 
adenosine deaminase have been employed in this type of scheme with 
supports such as silica or sol-gel capillary monoliths and in combination 
with two-dimensional LC or LC coupled with mass spectrometry [22, 
237–239]. Enzymes have also been immobilized on silica and used in a 
microextraction column to fish for xanthine oxidase inhibitors in natu-
ral products by using LC coupled with a diode array detector and tan-
dem mass spectrometry [22, 238]. 
Some enzymes have been employed as chiral selectors [243–247]. 
Examples of enzyme-based chiral stationary phases (CSPs) are those 
based on penicillin G acylase [243–245], glucoamylase [246], and cel-
lulase [247]. For instance, penicillin G acylase has been covalently 
immobilized with a silica monolith for the chiral separation of 2-ar-
yloxyalkonic acid methyl esters and isosteric analogs [245]. Cellu-
lase was recently employed as a CSP by covalently immobilizing it 
onto aminopropyl silica and using this stationary phase for the chi-
ral separation of various β-blockers [247]. Other examples are de-
scribed in Section 5.3. 
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4.1.5 Serum Proteins 
Serum proteins are one set of biological binding ligands that have been 
used for sample preparation and binding studies in affinity chromatog-
raphy [11, 248, 249]. HSA, BSA, AGP, and lipoproteins are examples of 
these binding agents. HSA and AGP act as the main carrier proteins for 
numerous drugs, low-mass hormones, and fatty acids in the human cir-
culatory system [11, 250, 251]. HSA is primarily involved in delivering 
acidic and neutral drugs, while AGP is the main carrier for basic drugs 
and steroids [250, 251]. 
Applications of these serum proteins in affinity separations have been 
the subjects of several recent reviews and papers [252–263]. One exam-
ple is their use as stationary phases in chiral separations [11, 252, 253], 
as is described in more detail in Section 5.3. Another use of these serum 
proteins has been in biointeraction studies (see Section 5.4) [254–262]. 
For example, several studies in recent years have used affinity columns 
to investigate the overall affinity and site-specific binding of various sol-
utes toward these carrier proteins [135, 141, 254–262]. The use of affin-
ity chromatography to develop structure-affinity relationships for sol-
utes with serum proteins has also been described [11, 135, 253, 256, 
257, 261]. In these studies, a change in structure for either a group of 
solutes or in the immobilized binding agent is made to see how this af-
fects the solute-binding agent interaction. Specific examples include re-
ports that have looked at how changes in the glycation of HSA or gly-
cosylation of AGP affect the ability of these serum proteins to bind to 
various drugs and drug classes [11, 135, 141, 262]. 
4.1.6 Biotin, Avidin, and Streptavidin 
The interactions of biotin with the proteins streptavidin and avidin have 
often been employed in affinity chromatography [220, 264–266]. Biotin, 
which is also known as vitamin H and vitamin B7, is a cofactor found in 
all living cells [220, 264–266]. Avidin is a glycoprotein that is found in 
egg white, while streptavidin is a protein produced by Streptomyces av-
idinii bacteria [220, 264–267]. Biotin affinity columns are usually pre-
pared by immobilizing 2-iminobiotin or native biotin to an LC support 
by employing the valeric acid side chain of these compounds [220]. Av-
idin or streptavidin can also be immobilized by using an approach such 
as the cyanogen bromide method [220].  
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It has been known for many years that biotin can undergo strong 
non-covalent interactions (i.e., with dissociation equilibrium constants 
as low as the picomolar-to-femtomolar range) with avidin and strepta-
vidin [265–267]. Although there are similar biotin interacting sites in 
both these proteins, streptavidin possesses stronger binding to biotin 
than avidin as it can form a greater number of hydrogen bonds with the 
valeryl carboxylate group of biotin [220, 264]. 
Biotin–avidin interactions have been employed for carrying out the 
purification of biotinylated proteins using native elution conditions as 
well as for the determination of biotin in food and beverages [268, 269]. 
Biotin–avidin interactions have also been recently used to study the in-
teractions of avidin on quantum dots with biotinylated IgG [270]. Inter-
actions based on biotin with streptavidin have been used for the identi-
fication and characterization of ligands specific to nanodisc-embedded 
G-protein-coupled receptors, the detection of human immunodeficiency 
virus-1 (HIV-1) in sub-attomole levels, and the extraction of streptavi-
din in the presence of green fluorescent protein and a cell lysate of E. coli 
[130, 145, 152]. A biotinylated ligand complex prepared by coupling an 
azo-based linker through click chemistry was immobilized on a strep-
tavidin support for the affinity independent elution of ligands [271]. 
Monolithic columns have been combined with biotin–streptavidin/
avidin systems for various applications [259, 272]. For instance, mo-
nomeric avidin that was attached to monoliths based on co-polymers 
of glycidyl methacrylate with ethylene dimethacrylate and acrylamide 
have been employed for the enrichment of biotinylated peptides and 
proteins [272]. Streptavidin–biotin interactions were also exploited by 
applying biotinylated HSA to streptavidin immobilized on silica- and 
organic-based monoliths that were used in nano-weak affinity chroma-
tography [259]. 
The fact that avidin and streptavidin have essentially irreversible 
binding to biotin means avidin/streptavidin–biotin complexes can only 
dissociate under harsh conditions, which can lead to the inactivation 
of some biotinylated biomolecules [267, 273, 274]. This has made ge-
netically or chemically modified forms of avidin or streptavidin of in-
terest for use in affinity applications [275]. Tamavidin 2-REV, a mutein 
engineered from tamavidin, was immobilized on agarose for the puri-
fication of biotinylated BSA and exhibited reversible binding for this 
target (dissociation equilibrium constant, 10−7 M) [275]. Core strep-
tavidin, a mutant of streptavidin, can undergo reversible interactions 
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with a strong affinity with biotin without being affected by harsh ex-
perimental conditions [276–279]; this form of streptavidin was fused 
with the transmembrane glycoprotein CD47 and isolated by using bi-
otinylated agarose [279]. 
4.1.7 Carbohydrates 
Carbohydrates have been used as immobilized ligands in chromato-
graphic methods to carry out chiral separations and other forms of se-
lective separations (see Section 5 for examples of applications) [3, 11, 
220, 280–284]. Polysaccharide-based stationary phases have been ex-
tensively used for the separation of chiral drugs and solutes as a result 
of their excellent enantioselectivity and an ability to be used in a vari-
ety of separation modes [3, 11, 112, 282, 283, 285, 286]. Most CSPs that 
employ  polysaccharides are based on 3,5-dimethyl phenyl carbamate 
or 3,5-dichloro phenyl carbamate derivatives of cellulose and amylose, 
which can be prepared by coating or immobilizing these chiral agents 
onto supports such as porous silica particles, silica monoliths, or super-
ficially porous silica [11, 280, 283, 285–287]. 
Other polysaccharides such as derivatives of chitin and chitosan have 
also been recently employed for chiral separations. Some attractive fea-
tures of these polysaccharides are their insolubility in many organic 
solvents (e.g., as may be used as a mobile phase) and their comparable 
enantioselectivity to cellulose or amylose derivatives for some applica-
tions [281, 282]. In the case of chitin, N-acetyl-d-amine glucose units 
are bonded together by β-(1→4) glycoside bonds, with deacetylation of 
chitin resulting in the formation of chitosan [281, 282, 284]. Most chi-
tosan- and chitin-based chiral selectors have made use of arylcarba-
mate or 3,5-dimethyl carbamate derivatives of chitosan and chitin [284, 
288–295]. 
Cyclic oligosaccharides composed of α-1,4-linked d-glucopyranose 
units, such as β-cyclodextrin, have also been frequently employed as 
CSPs [11, 112, 282, 283, 296, 297]. The glucopyranose units in these cy-
clodextrins are arranged in a circular polymer which has a hydropho-
bic cavity and an exterior that is hydrophilic [112, 282, 283, 296, 297]. 
Some chiral solutes can form inclusion complexes with the hydropho-
bic cavity and undergo differential interactions to the hydroxyl groups 
that are at the mouth of the cyclodextrin cavity [112, 282, 296, 297]. 
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Host–guest interactions between chiral solutes and cyclodextrins mainly 
occur through hydrogen bonds, hydrophobic forces, π–π bonding, and/
or ionic interactions [112, 282, 296, 297]. These CSPs can be prepared 
by coating or covalently immobilizing a cyclodextrin to the desired chro-
matographic support [11, 112]. Recently, immobilization strategies for 
β-cyclodextrin using click chemistry [298–302], monolithic supports 
[303], hybrid chromatographic supports [304, 305], and light-assisted 
preparation of the CSP [306] have also been reported. 
CSPs that are based on derivatized β-cyclodextrins may suffer from 
a loss of enantioselectivity due to exhaustion of hydroxyl groups that 
were originally present on the rim of the cyclodextrin or due to the ste-
ric hindrance caused by a large number of substituents at or near the rim 
of the cyclodextrin [307, 308]. Several new forms of cyclodextrin sup-
ports, or studies of current cyclodextrin materials, have been recently 
reported to overcome these disadvantages. For example, a bridged bis(β-
cyclodextrin) has been utilized as a new ligand for chiral separations and 
has been noted to possess strong hydrogen bonds, synergistic inclusion 
effects, and good molecular assembly, which can lead to improved chi-
ral separations [307, 308]. This type of stationary phase consists of two 
β-cyclodextrin units that are connected together by a linker such as eth-
ylene-diamine dicarboxyethyl diamido or stilbene diamido, which has 
been proposed to provide additional binding regions by creating pseudo-
cavities [307, 308]. A chiral mixed-mode stationary phase has also been 
prepared by grafting ionic liquids with β-cyclodextrin and C18 on silica; 
these materials have been found to exhibit retention based on reversed-
phase, hydrophilic, and ion-exchange mechanisms [309]. 
The methods of peak profiling and peak fitting, respectively, have 
been used to study the kinetics and thermodynamics of interactions by 
immobilized β-cyclodextrin  with various solutes [310–313]. For exam-
ple, peak profiling based on both single- and multi-flow rate methods 
was used to measure the apparent dissociation rate constants for vari-
ous drugs with immobilized β-cyclodextrin [310, 311]. Peak fitting was 
used under non-linear conditions to determine the binding and rate con-
stants for acetaminophen, trimethoprim, ketoprofen, indapamide, and 
uracil with immobilized β-cyclodextrin [310]. 
Macrocyclic oligosaccharides such as aliphatic and aromatic cyclo-
fructans (CFs) have also been utilized in chiral separations [281, 314]. 
These compounds are classified based on the number of fructose units 
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they contain in their structure, with examples being cyclofructan 6, cy-
clofructan 7, and cyclofructan 8 [281, 314]. These cyclofructans are ei-
ther partially derivatized into an aromatic or aliphatic form and coupled 
to silica or they are first combined with a silica support and then deriva-
tized into one of these forms [281, 314–318]. Click chemistry has also 
been used to prepare cyclofructan CSPs [319]. 
Another type of carbohydrate-related agent that has been used in 
affinity separations is heparin. Heparin is a glycosaminoglycan that is 
structurally related to heparan sulfate and is an important receptor for 
virus attachment in mammalian cells [320]. This property means hepa-
rin can be used to bind to viral particles [320]. Based on this ability, hep-
arin has been employed in affinity chromatography for the purification 
of porcine reproductive and respiratory syndrome viral particles, and 
human papillomavirus type 16 L1 protein from Saccharomyces cerevi-
siae, as well as the separation of HIV-1 gag viral-like particles and extra-
cellular vesicles [320–322]. 
4.1.8 Lipids 
Lipids are another class of biological ligands that have been employed 
in affinity chromatography and related separation methods. Phospha-
tidylcholine is a phospholipid that is extensively employed in applica-
tions that involve lipid supports, such as immobilized artificial mem-
brane chromatography and immobilized liposome chromatography [3, 
11]. Phosphatidylcholines are glycerophospholipids that contain a glyc-
erol backbone, two fatty acids coupled together by ester linkages, and 
a choline head group [323, 324]. Other lipids such as sphingomyelin 
and cholesterol have also been employed in immobilized artificial mem-
branes and other supports that have been used in separations [3, 11, 
325]. Sphingomyelins are based on ceramide and consist of a long-chain 
sphingoid base with an amide-linked acyl chain and a phosphorylcho-
line head group [323, 324]. Cholesterols are sterols that contain a four-
ring hydrocarbon structure [323, 324]. 
Immobilized artificial membrane chromatography, or IAM, is one for-
mat in which lipids have been employed as affinity ligands to study mem-
brane protein–substrate interactions and membrane–drug interactions 
[311, 326]. The stationary phase in IAM is prepared by covalently im-
mobilizing a monolayer of phospholipid analogs with functional head 
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groups, which are attached to silica or a polymeric monolithic support. 
This type of support creates a hydrophobic environment for the adsorp-
tion and immobilization of transmembrane proteins such as receptors, 
transporters, ion channels, and enzymes [326–336]. Solubilized cellular 
membrane fragments can be immobilized on IAM supports through en-
trapment or adsorption after dialysis  [326–336]. For example, voltage-
dependent anion channel isoform 1 (VDAC-1) has been immobilized on 
lecithin-functionalized silica gel for the screening of anti-cancer com-
pounds found in traditional Chinese medicine [330]. This receptor sup-
port was also used to study the interactions of VDAC-1 with ligands such 
as NADH, ATP, and NADPH [330]. IAM has further been used to study 
the partitioning of drugs into lipid monolayers to predict drug absorp-
tion and cell permeability [337–339]. 
Immobilized liposome chromatography, or ILC, is a type of affinity 
chromatography in which lipid bilayers or proteoliposomes are immo-
bilized on a support through non-covalent steric, electrostatic, hydro-
phobic, or covalent interactions [340–347]. The liposome membrane is 
composed of self-aggregates of a structured phospholipid with charged 
choline or phosphate groups, a carbonyl group, and a hydrophobic envi-
ronment; the result is considered structurally similar to a cell membrane 
[121, 348–350]. Proteoliposomes can act as biomimetic membranes to 
reconstitute membrane proteins [121, 348–350]. For instance, a deter-
gent-solubilized membrane protein, photosynthetic reaction center (RC) 
from Rhodobacter spaheroides, was functionalized with a biotinylated 
lipid and immobilized on streptavidin beads to study the interactions by 
RC to c-type cytochromes [350]. ILC has also been applied to study the 
interactions of drugs with membranes and to screen for membrane-pen-
etrable compounds [340–347]. As an example, liposomes immobilized 
in capillary columns containing silica monoliths have been utilized to 
separate acidic, basic, and neutral drugs [346]. Liposomes immobilized 
on silica microspheres have been employed for the screening of bioac-
tive compounds in some types of traditional Chinese medicine [340]. A 
support containing N-hexadecyl iminodiacetic acid was used to adsorb 
Cu2+ on liposomes for the purification of his-tagged proteins [351]. Lipid 
metal ion interactions have also been studied using ILC [352, 353], as 
has been demonstrated in the use of a zwitterionic lipid immobilized on 
non-porous Stober silica particles to examine interactions of the lipid 
with group I and II metal ions [352]. 
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Lipids can also be employed as biomimetic membranes in the form 
of lipodiscs, nanodiscs, and lipid rafts [130, 321, 322, 351]. Lipodiscs 
are made up of a circular planar bilayer that is usually stabilized by lip-
ids modified with polyethylene glycol head groups; these lipodiscs can 
then be covalently immobilized on diol silica [354]. The intra- and ex-
tracellular sides of the lipodiscs are exposed to the bulk solution; this 
means that when the lipodiscs are functionalized with membrane pro-
teins, the active site of the membrane protein will be exposed to the sur-
rounding environment [354]. In one recent report the integral mem-
brane protein human aquaporin-1 was immobilized on lipodiscs and 
used in WAC for the fragment screening of integral membrane proteins 
[354]. Nanodiscs are composed of self-assembled bilayers of phospho-
lipids and a membrane scaffold protein (e.g., from human serum apoli-
poprotein A1) [130]. The nanodiscs have been immobilized on mono-
liths modified with streptavidin and by using a biotinylated membrane 
scaffold protein (adenosine A2A receptor) for the detection of G-protein-
coupled receptor-bound weak affinity fragments [130]. Lipid rafts con-
sist of microdomains that are enriched in dynamic assemblies of sphin-
golipids or cholesterol, as have been used on silica for the screening of 
anti-cancer agents in traditional Chinese medicine [324, 325].  
4.1.9 Nucleic Acids 
Another set of biological binding agents that have been used in affin-
ity chromatography is nucleic acids [355–364]. For instance, DNA is 
used as the affinity ligand in the method of DNA affinity chromatog-
raphy to bind and isolate DNA-binding proteins [355–362]. Examples 
of proteins that bind DNA and that have been purified or isolated by 
this approach include helicases, restriction enzymes, polymerases, pri-
mases, topoisomerases, teleomerases, DNA repair proteins, histones, 
and transcription factors [355–359, 363, 364]. The binding agent that 
is used in this approach may be either a general preparation of frag-
mented nuclear DNA or a specific section of DNA. A general prepara-
tion would be used to separate DNA-binding proteins from sample 
components that are not able to bind DNA [355]. A specific section of 
DNA would be employed as the ligand in a situation where the goal is 
to bind a target that has a specific interaction with the selected DNA 
section or sequence [355, 364]. 
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Another group of ligands that are typically based on nucleic acids 
are aptamers [365]. Aptamers are synthetic oligonucleotide sequences 
(i.e., DNA and RNA) that are tailored to bind to specific target mole-
cules [365–367]. These targets may include proteins, nucleotides, vi-
ruses, or small molecules. Aptamers are often generated through a se-
lection process called the systematic evolution of ligands by exponential 
enrichment (SELEX) [365–370]. SELEX is a technique that can be used to 
screen for and amplify (e.g., the polymerase chain reaction) a specific oli-
gonucleotide sequence that has a high affinity toward the desired target, 
beginning with an initial large library of potential binding agents [365]. 
In affinity chromatography, an aptamer can serve as a stationary phase 
by immobilizing this agent onto a column and using this to interact with 
a particular target analyte [366, 370]. Target recognition with this type 
of binding agent is based on the unique three-dimensional structure of 
the aptamer, which can form pockets and interaction regions with rela-
tively high affinities and good specificities [368, 369, 371]. These advan-
tages, along with the ability to generate aptamers by synthetic means and 
through combinatorial methods, have made this group of affinity ligands 
attractive in recent studies as alternatives to antibodies [372–375]. 
Aptamers have been used as binding agents in columns to bind both 
small and large targets [376–386]. Small molecules like mycotoxins and 
aflatoxin have been purified and enriched by aptamer affinity chroma-
tography [379, 381–383, 386]. Columns containing aptamers have also 
been used to isolate recombinant proteins and therapeutic monoclonal 
antibodies [377, 379, 384]. Monolith columns containing aptamers have 
been described [376, 378, 383, 386], and aptamers have been combined 
with multi-walled carbon nanotubes and gold nanoparticles for protein 
purification [376, 380]. 
4.2 Non-Biological Agents as Affinity Ligands 
A variety of non-biological binding agents are also often considered to 
be stationary phases that fall within the field of affinity chromatography 
(see Table 3). Examples of these binding agents are boronates, dye-li-
gands, immobilized metal ion chelates, and molecularly imprinted poly-
mers [1, 3]. This section will examine the basis  behind the use of each 
of these binding agents as affinity ligands and recent developments that 
have occurred with these stationary phases. 
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4.2.1 Boronates and Related Mixed Ligands 
Boronates have emerged as a useful and reliable set of affinity ligands for 
the selective recognition, separation, and enrichment of glycoproteins, 
nucleosides, catecholamines, and other cis-diol-containing compounds 
[387–390]. Targets that contain cis-diol groups are often important in 
fields such as glycomics, cancer-cell targeting, and disease diagnostics 
[391–398]. The principle of boronate affinity chromatography (BAC) is 
based on the covalent formation of a cyclic ester when boronic acid or 
one of its derivatives reacts with a cis-diol-containing molecule. This re-
action usually takes place when the pH of the reaction environment is 
greater or equal to the pKa of the boronate that is used as the binding 
agent. This cyclic ester dissociates when the pH of the environment is 
below the pKa of the binding agent, which allows for elution and release 
of the captured target [387–390]. 
Some common boronates that are used as ligands in BAC are 3-ami-
nophenylboronic acid and 4-vinylphenylboronic acid, which have pKa 
values of 8.8 and 8.2, respectively [389, 390]. However, the use of these 
boronate ligands is hampered in terms of the weak binding properties 
they have at the typically more neutral pH of biological samples [389, 
Table 3 Types of Non-Biological Binding Agents Used in Affinity Chromatography 
Type of Binding  
Agent  Targets  Examples of Applications 
Boronates  cis-Diol containing compounds:  Boronate affinity chromatography; 
    glycoproteins, nucleosides,    boronic acid-lectin affinity 
    catecholamines       chromatography; biospecific  
     adsorption 
Dye-ligands  Various enzymes and proteins  Dye-ligand affinity chromatography;   
    purification of enzymes and  
     proteins 
Metal-ion   Various biological agents that Immobilized metal-ion affinity 
   chelates     bind to specific metal ions      chromatography; purification  
     of his-tagged proteins;  
     enrichment and extraction  
     of phosphopeptides 
Molecularly  Targets that are complementary  Solid-phase extraction; 
   imprinted     to the binding pockets formed            chiral separations 
   polymers   within the imprinted polymer  
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390, 399–402]. This has given rise to the synthesis and use of new bor-
onates with lower pKa values, such as Wulff-type boronic acids, benzo-
boroxoles, phenylboronic acids with electron-withdrawing groups (e.g., 
sulfonyl, fluoro, or carbonyl groups) on the phenyl ring, and heterocyclic 
boronic acids [90, 390, 403–417]. These boronic acid ligands have been 
shown to have enhanced binding at neutral or acidic pH values compared 
with conventional boronates, leading to improved binding strength and 
extraction efficiency [390, 403, 418–420].   
Boronate ligands and BAC have been used in many recent applications 
[402]. Examples are the use of boronates and BAC for the enrichment, se-
lective separation, and analysis of nucleosides, flavones, glycoproteins, 
glycopeptides, carbohydrates, and other cis-diol-containing compounds. 
These applications have been carried out with such matrices as urine, se-
rum, and other biological samples that could be processed under acidic or 
neutral pH conditions [402, 404–407, 410, 415–418, 421–431]. 
Mixed affinity ligands based on boronates plus other binding agents 
have also been used for the separation of biomolecules in affinity chro-
matography. One example is the combination of a boronic acid and lectin 
to give a method known as boronic acid-lectin affinity chromatography, 
which is also referred to as BLAC or BAD-lectin affinity chromatogra-
phy [432–435]. This combination overcomes the difficulty of using bo-
ronic acids to differentiate different glycoforms, as can be achieved by 
adding a lectin to the same stationary phase [432, 435]. Although the 
number of lectins that have been used in this approach is still limited, 
these binding agents have been used with boronates to purify, with high 
specificity, some classes of glycans with cis-diol groups [435, 436]. The 
stationary phase in this method is often prepared by mixing a support 
that contains an immobilized lectin with another support that contains 
a boronate [433, 435]. BLAC is usually used for comparative glycosyl-
ation profiling. For example, a BLAC column was used to isolate and en-
rich N-linked glycans labeled with 8-aminopyrene-1,3,6-trisulfonic acid 
(APTS) from prostate cancer patients [433] and N-linked glycopeptides 
from HeLa cells [435]. 
4.2.2 Dye-Ligands 
A dye-ligand is another type of synthetic binding agent that has been 
used in affinity chromatography [365, 437, 438]. This combination is 
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sometimes called dye-ligand affinity chromatography, which is a type 
of biomimetic affinity chromatography [365]. A common example of a 
dye-ligand is Cibacron Blue 3GA. Other examples are Procion Red HE-
3B and Procion Yellow H-A [365, 437]. Dye-ligands typically consist of 
two parts: a portion that binds to the given target and a reactive group 
for covalent attachment of the dye to a support [365, 437, 438]. 
The earliest application of a dye-ligand for affinity chromatography 
was the use of Blue Dextran for enzyme purification [439]. Dye-ligands 
are now commonly used in columns for protein and enzyme purification 
due to the ability of such ligands to interaction with a variety of proteins 
and the ability to modify the structure of the dye-ligand to alter its spec-
ificity [437, 438, 440, 441]. The modification of a dye-ligand and the de-
sign of derivatives for a given target can be aided by using computational 
chemistry [440]. Recent reported applications of dye-ligands as binding 
agents in affinity chromatography have involved the use of these agents 
for the purification of fucosidan, lactoferrin, and lactoperoxidase from 
food by-products and biological matrices [442–445]. 
4.2.3 Immobilized Metal-Ion Chelates 
Metal ions held in the form of immobilized chelates are another type of 
non-biological binding agent that has been employed in affinity chro-
matography [3, 446].  This method is known as IMAC [3, 446]. IMAC is 
based on the interaction between chelated metal ions and residues on 
some amino acids (e.g., cysteine, histidine, and tryptophan) that can act 
as electron donors [446–448]. In IMAC, a chelating agent is immobilized 
onto a material such as silica, cellulose, agarose, or a cryogel and used 
to hold metal ions through coordination bonds [446–451]. 
Selection of the proper chelating ligand and metal ions can affect the 
stability of this metal-chelating agent complex and the resulting retention 
of targets that bind to this support. Iminodiacetic acid (IDA), nitrilotriace-
tic acid (NTA), carboxymethylated aspartic acid (CM-Asp), diethylene tri-
amine pentaacetate (DTPA), and tris(carboxymethyl) ethylene-diamine 
(TED) are some examples of chelating ligands that have been used in IMAC 
[446–448, 450]. Metal ions like Ni2+, Cu2+, and Zn2+ are typically used to 
bind targets that contain nitrogen, oxygen, or sulfur atoms that are acces-
sible. On the other hand, metal ions such as Cu+, Ag+, Pd2+, Cd2+, and Hg2+ 
can be used to bind targets that contain sulfur [447, 449, 450, 452]. 
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IMAC has been employed in the selection of DNA aptamers and in pro-
tein purification for targets such as Fab fragments, monoclonal antibod-
ies, and phosphopeptides [451, 453–465]. In proteomics, IMAC has taken 
on an important role in the enrichment and extraction of phosphopep-
tides from samples [454–458]. Some recent platforms that have been re-
ported include the use of IMAC with magnetic microspheres, O-carboxy-
methyl chitosan Schiff base complexes, and capillary-channeled polymer 
fibers [458, 463–465]. Hybrid methods that combine IMAC and capil-
lary electrophoresis (CE) or that use multi-dimensional IMAC to purify 
analytes from a complex sample have also been described [459, 466]. 
4.2.4 Molecularly Imprinted Polymers 
Molecular imprinting is an alternative strategy for preparing supports 
and stationary phases for affinity chromatography [467–469]. This tech-
nique makes use of a support that has binding pockets prepared within 
it for binding recognition with the desired target [469]. A support that 
is prepared in this way is often known as a MIP [467]. A MIP is often 
made by either a covalent or non-covalent technique. In the non-cova-
lent imprinting approach, the target analyte or template is mixed with 
a functional monomer and cross-linking agent. After this mixture is al-
lowed to polymerize, the template or target is washed away, leaving be-
hind binding pockets that have the correct shape and arrangement of 
functional units to bind to the desired target [467–469]. In covalent im-
printing, the target molecule is covalently coupled to a functional mono-
mer that is combined with the rest of the polymerization mixture. After 
polymerization, the target is cleaved away by a chemical means, leaving 
behind a cavity that can bind the target molecule [467, 469, 470]. Ionic 
imprinting can also be utilized, in which metal ions act to enhance bind-
ing by the target analyte and functional monomer in an aqueous solu-
tion [467, 469, 470]. 
Molecular imprinting has been used in many reports to make sup-
ports for chiral separations; however, it has also been widely used in 
solid-phase extraction and some chromatographic techniques [467–
479]. For example, a MIP support has been used for solid-phase ex-
traction and coupled with ligand exchange chromatography to screen 
for chiral drugs in urine [475]. MIPs have also been employed in many 
studies  for the binding and isolation of low-mass targets and have 
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been developed for use with larger molecules like proteins in applica-
tions such as diagnostics, drug delivery, environmental analysis, and 
proteomics [467–482]. 
5 Applications of Affinity Chromatography 
The applications of affinity chromatography have grown over the course 
of the last decade [3]. These applications have included the utilization 
of this method for the isolation of various chemicals and biochemicals, 
as well as the use of affinity chromatography for sample pretreatment 
or analysis [1–8]. There has also been continued work in using affin-
ity-based separations as tools to study biochemical interactions [1, 3]. 
As shown in Figure   3, fields in which one or more of these formats 
have been employed include biochemistry and biochemical research, 
molecular biology, biotechnology, microbiology, cell biology, immunol-
ogy, analytical chemistry, pharmacology or pharmaceutical sciences, and 
biophysics [1–8]. Other areas of chemistry and related fields in which 
affinity chromatography has been used are clinical chemistry, environ-
mental chemistry, and food science [1, 3]. This section will examine the 
recent developments that have taken place in applications of affinity 
chromatography and the use of this method in these various areas. 
5.1 Preparative Applications 
One of the most popular uses of this technique has continued to be in 
the purification of biological ligands. A variety of binding agents can be 
used for this purpose. Examples are immunoglobulin-binding proteins, 
antibodies, and antigens, as discussed earlier in Section 4.1 [221–229]. 
5.1.1 Enzyme and Protein Purification 
The separation and purification of enzymes have long been an important 
application of affinity chromatography [3, 438, 439]. Examples based 
on triazine dyes as affinity ligands are the use of Cibacron Blue F3GA to 
isolate microbial cellulase from rumen liquor [483], microbial xylanase 
from rumen liquor [484], and proteases from pancreatic and stomach 
extracts of fish by-products [485]. Hemicyanine dye has been used in a 
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similar manner to isolate peroxidase from a chewing stick [486], and 
aminosquarylium cyanine dye has been employed for the purification 
of lysozyme, α-chymotrypsin, and trypsin [487]. Azo dyes such as Re-
active Orange 4 were utilized for the purification of malate dehydroge-
nase from a yeast cell homogenate [42]. 
IMAC can also be employed for the separation of enzymes. This 
method is based on the interactions between a metal ion conjugate 
such as Cu2+- or Zn2+-IDA that is placed onto a chromatographic support 
and used to bind to histidine or cysteine residues [488–490]. In recent 
work, a support containing Cu2+ complexed with IDA was employed for 
the isolation of metalloprotease from a marine bacterium and for the 
isolation of his-tagged chitinase [488, 489]. In a similar manner, Zn2+-
IDA has been utilized in an affinity method for the capture of camel 
liver catalase [490]. 
Coenzymes and enzyme inhibitors are additional affinity ligands 
that have been utilized for the purification of enzymes [25, 181, 491–
494]. 4-Aminobenzohydrazide and its derivatives have been used as en-
zyme inhibitors for the purification of plant peroxidase enzymes from 
red cabbage and radishes [492, 493]. In addition, the enzyme inhibitor 
β-lactosylamidine has been utilized for the purification of a cellulolytic 
Figure   3 Common applications of affinity chromatography. This figure is based on a 
search of the literature that was made with SciFinder in January 2019 for papers (to-
tal of 46,335 obtained) in the indicated areas and that were linked to the term “affinity 
chromatography.” The figure is reproduced from Ref. [3] with permission from Elsevier.
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β-glucosidase mixture of endo-acting endo-β-(1→4)-glucanase I and exo-
acting cellobiohydrolase I from Hypocrea jecorina [491]. Sulfanilamide 
has been recently used as an inhibitor-based binding agent for lactoper-
oxidase in milk [181]. Riboflavin, a coenzyme which is flavin adenine di-
nucleotide (FAD)-dependent, was immobilized on Sepharose beads and 
used to isolate cholesterol oxidase, a FAD-dependent enzyme expressed 
in E. coli [494]. 
Affinity chromatography is also an important tool for the purifica-
tion of other types of biomolecules [1, 2, 4–8]. This includes the utili-
zation of affinity chromatography for the small- and large-scale purifi-
cation of native proteins and recombinant proteins. Dye-ligand affinity 
chromatography and related methods are often used for this purpose 
[1, 2, 4–8, 365, 438, 440, 495, 496]. Smaller-scale applications of affin-
ity methods for purification include the use of IMAC and Ni2+ chelate col-
umns for the isolation of his-tagged proteins and the capture of anti-
bodies or specific antigens by immunoaffinity columns [207, 208, 210, 
220, 446, 448, 497, 498]. 
5.1.2 Purification of Viral Particles, Cells, and Related Targets 
Affinity ligands attached to polysaccharide supports such as agarose or 
cellulose have been employed for the purification of viral particles and 
related agents [320]. Heparin is one ligand that has been covalently im-
mobilized on agarose beads for the purification of whole viruses and 
virus-like particles [320–322]. Con A and camelid  antibody fragments 
have both been used as binding agents for the purification of recombi-
nant virus vectors in gene and cellular therapy [499, 500]. Affinity chro-
matography utilizing Cellufine sulfate as a binding agent has been used 
for the isolation of Japanese encephalitis virus derived from Vero cells, 
as well as for purification of the whole virus produced in Vero cell cul-
tures for the development of a yellow fever vaccine [501–505]. 
The interactions between metal ion chelates and amino acid residues 
in IMAC have been used in several reports for applications related to vi-
ruses and viral proteins. This approach has been employed for the pu-
rification of his-tagged nucleocapsid and matrix proteins of the Nipah 
virus [506, 507]. This method has also been used to isolate his-tagged 
recombinant viral vectors that are related to gene therapy [508] and the 
virus responsible for foot-and-mouth disease virus for use in vaccine 
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formulation [509]. IMAC has further been used to purify the hepatitis B 
viral protein HBcAg from E. coli cell lysates [510, 511]. Cu2+-based IMAC 
has been employed for the inactivation of viruses during the manufactur-
ing process of plasma coagulation factors such as plasma-derived coag-
ulation factor VIII and coagulation factor IX (Replenine-VF) [512, 513]. 
Antibody-binding proteins and antibodies attached to agarose-based 
supports have been both used to examine viral clearance [320, 514–
517]. For example, native protein A [516] and alkali-stabilized recombi-
nant protein A [515] have been employed for clearance studies involving 
endogenous retroviral particles that are present in antibody feedstock. 
Monoclonal antibodies to recombinant coagulation factor VIII have been 
used for the purification of antihemophilic factor VIII compounds [513, 
518–520]. The latter approach has also been used in a mixed-mode 
resin to extract and purify a recombinant factor VIII with a truncated 
B-domain [521]. 
Cell affinity chromatography is a recent form of bioaffinity chroma-
tography that has been used to isolate and separate certain cells with 
high purity [22, 522, 523]. Cell separations in this technique are carried 
out based on the interaction between binding agents such as lectins or 
monoclonal antibodies with cell surface markers such as glycoproteins 
and receptors [522–524]. Some supports that have been used in cell af-
finity chromatography are magnetite and several forms of monoliths 
[524– 527]. The separations of cell subsets with a high purity and on a 
small scale have been accomplished by combining a microfluidic device 
with the use of aptamers as binding agents [528–532]. Cell affinity chro-
matography has also been recently employed for counting cancer cells 
in samples, examining microbial interactions with specific glycans, and 
following the viral infection of cells [525, 530–533]. 
5.2 Analytical Applications 
Many of the same binding agents described earlier have made affinity 
chromatography a useful tool in analytical applications employed for 
sample pretreatment and preparation [3, 11, 219, 534–536]. Most of 
these applications employ the on/off elution mode of affinity chroma-
tography, as shown earlier in Figure   1, due to the relative simplicity 
and speed of this approach [3, 5, 219]. However, isocratic elution is also 
used when the interactions involved have weak or moderate binding 
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strengths,  as occurs in WAC. This second situation is commonly used in 
the use of affinity chromatography in chiral separations, as discussed 
in the next section. 
One way in which affinity chromatography is often used for chemical 
analysis is as a tool for sample pretreatment [1, 3, 219, 534–536]. For ex-
ample, MIPs have been employed in solid-phase extraction as a means of 
sample preparation for the analysis of various target compounds [211, 
473, 475]. Columns and supports that contain antibodies have been used 
in many reports for the immunoextraction of a specific target from a mix-
ture prior to the use of a second analytical method such as HPLC, gas 
chromatography (GC), mass spectrometry, or capillary electrophoresis 
(CE) [208, 210, 219]. These techniques, which are a type of IAC, have 
been used for examining targets in a variety of clinical, pharmaceutical, 
and environmental samples [210, 219, 537]. A related application of af-
finity chromatography is immunodepletion, in which a set of specific 
agents are removed from a sample prior to the analysis of other sample 
components [46]. Immunodepletion has been used in recent studies as 
a means for removing proteins that occur at a high abundance prior to 
analysis of lower abundance proteins [46, 537–539]. 
It is also possible to use affinity chromatography to directly measure 
a particular target in a sample [3, 219]. This is often done by using af-
finity chromatography as part of HPLC systems, and often in the form of 
HPAC. Binding agents that have been used for this purpose are antibod-
ies/antigens, immunoglobulin-binding proteins (e.g., protein A or pro-
tein G), immobilized metal ion chelates (i.e., IMAC), boronates, and lec-
tins [534–536]. Direct detection of the captured and eluted target can be 
carried out in these methods if this target is present at a sufficient con-
centration to allow it to be monitored by its absorbance or fluorescence, 
by using mass spectrometry, or by employing a post-column reactor for 
detection [208, 219]. Affinity columns have further been employed in 
multi-dimensional methods by combining them with reversed-phase 
liquid chromatography, CE, or GC [219]. 
Targets that are present at low concentrations can be detected by 
using affinity chromatography with indirect detection. This strategy is 
often employed when affinity columns are used with antibodies or re-
lated binding agents to create a chromatographic immunoassay [208, 
210, 219]. For example, a target analyte may be required to compete 
with a labeled analog for binding sites on an immunoaffinity column 
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that contains a limited amount of immobilized antibodies for the target 
and analog. This creates a situation in which the amount of labeled an-
alog that is captured will be affected by the amount of target that was 
present in the sample, thus providing a means for indirectly determin-
ing the sample concentration for the target [208, 210, 219]. Many for-
mats have been described for chromatographic immunoassays. These 
formats include traditional competitive-based methods, as well as dis-
placement assays, sandwich assays, and one-site immunometric assays 
[210, 217, 219, 540–544]. 
5.3 Chiral Separations 
Chiral separations are another important application of affinity chroma-
tography [3, 11, 220, 280–284]. Polysaccharides such as amylose and 
cellulose have  been used as CSPs to carry out enantioseparation of var-
ious chiral drugs and solutes [3, 112, 280, 282, 283, 285, 286]. Examples 
that have used amylose-based CSPs have included the chiral separation 
of chemopreventive chiral isothiocyanates, pesticides, β-amino acid de-
rivatives, lysine derivatives, coumarin derivatives, butyrolactones, and 
fungicides [545–551]. Other applications have included sulfoxide-con-
taining drugs, antihistamines, simendan, piperine-2,6-diones, local anes-
thetics, calcium channel blockers, clausenamidone/neuclausenamidone, 
anticholinergic drugs, and various profens [547, 552–558]. Additional 
examples have used cellulose-based CSPs in HPLC for the separation 
of sulfoxides, alkaloid analogs, β-blockers, local anesthetics, β-amino 
acid derivatives, anti-fungal drugs, and psychoactive drugs [548, 555, 
559–564]. 
Various chitin and chitosan derivatives have been used as CSPs [281, 
282, 288– 295]. These stationary phases have been used for the chiral 
recognition of solutes such as benzoin, triazole fungicides, Troger’s base, 
and methylphenyl sulfoxide [288, 289, 291–294]. This class of CSPs has 
further been employed in enantioselective separations of voriconazole, 
glutethimide, citalopram hydrobromide, 1-phenyl ethane- 1,2-diol, and 
flavanone [288, 289, 291–293]. 
As discussed in Section 4.1.7, derivatives of β-cyclodextrin have often 
been exploited in affinity chromatography and HPLC systems to carry out 
chiral separations [11, 112, 282, 283, 296, 297]. Cationic β-cyclodextrin 
CSPs prepared by click chemistry have recently gained popularity for the 
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chiral selection of analytes such as β-blockers, racemic β-nitro ethanol 
derivatives, profens, amino acid derivatives, flavonoids, aromatic alco-
hols, acidic drugs, benzene homologues, and isoxazolines [298–302]. A 
hybrid support prepared by coupling β-cyclodextrin with piperidine, 
L-proline, and an ionic liquid with 3,5-diamino-1,2,4-triazole has been 
used to separate pyrrolidine and several chiral drugs [304]. Another hy-
brid support made by hybridizing β-cyclodextrin with ethane, triazinyl, 
and 3,5-dimethyl phenyl functional groups has been applied for enanti-
oselective separation of anilines, phenols, aromatic hydrocarbons, phe-
nols, and acidic compounds [305]. 
Several variations on cyclodextrin-based CSPs and related station-
ary phases have been described in recent reports. β-Cyclodextrin im-
mobilized on monolithic supports has been employed for separa-
tion of β-blockers, α-blockers, anti-fungal drugs, catecholamine, 
sedative hypnotics, anti-arrhythmic drugs, and antihistamines [303]. 
β-Cyclodextrin CSPs prepared by light assistance have been utilized for 
separating promethazine, benzoin, and chlortrimeton [306]. Bridged bis 
(β-cyclodextrin)-based CSPs have been used for the separation of chiral 
drugs, pesticides, and triazole fungicides [307, 308]. A mixed-mode sta-
tionary phase based on β-cyclodextrin has been utilized for the enan-
tioseparation of warfarin, styrene oxide, and 1-phenyl-1-propanol us-
ing reversed-phase elution conditions, while profens such as ibuprofen 
and ketoprofen were separated by this material and employing a polar 
organic elution mode [309]. Aromatic derivatives of the macrocyclic oli-
gosaccharide cyclofructan have been utilized for the chiral recognition 
of analytes such as warfarin, furoin, Troger’s base, 2-napthol atropiso-
mers, and novel spirobassinin analogs [315–318]. A cyclofructan 6 CSP 
prepared by click chemistry has been employed for the chiral selection 
of amine and alcohol derivatives [319].  
Proteins such as serum proteins and enzymes have also been em-
ployed as CSPs [3, 11, 112, 283]. Serum proteins such as HSA [68, 565, 
566] and AGP [567–570] have been immobilized on silica particles or 
monoliths to study the interactions of these proteins with chiral solutes. 
For instance, AGP from chicken egg white was covalently immobilized 
on aminopropyl silica for the chiral recognition of benzoin, ibuprofen, 
chlorpheniramine, propranolol, and oxprenolol [570]. An affinity sup-
port that contained HSA covalently immobilized to silica and modified 
with the cross-linking agent bis-maleimidohexane was prepared and 
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examined for its chiral selection of drugs such as warfarin, verapamil, 
and carbamazepine [566]. A related serum protein, BSA, has been used 
as in a mixed-binary CSP that was prepared by grafting BSA and the an-
tibiotic eremomycin for chiral separation of various profens [571]. 
The ability of enzymes such as penicillin G acylase, glucoamylase, and 
cellulase to act as CSPs was discussed in Section 4.1.4 [243–247]. Re-
cently, lysozyme was covalently immobilized to mesoporous polyimide 
achiral covalent organic frameworks for the chiral separation of various 
amino acids and drugs, such as threonine, leucine, tryptophan, ofloxa-
cin, metoprolol, and chlorpheniramine [572]. Pepsin has been covalently 
immobilized within silica monoliths and used to carry out a chiral sep-
aration for the analgesic nefopam [573]. 
As mentioned in Section 4.2.4, MIPs are another type of material that 
have frequently been explored for use as CSPs [283, 574]. Various po-
lymerization techniques have been applied for the preparation of MIP-
based CSPs. Examples of these techniques are imprinting in preformed 
beads, precipitation polymerization, suspension polymerization, multi-
step swelling and polymerization, and surface imprinting [575–582]. 
Supports with which MIPs have been combined for chiral separations 
include organic polymer-based particles, monoliths, membranes, and 
alignate monospheres [583–590]. For example, a MIP-based CSP using 
monodisperse hybrid silica microspheres was prepared with l-phenyl-
amine as the template, methacrylic acid and acryloyl-β-cyclodextrin as 
the functional monomers, and ethylene glycol dimethacrylate as the 
cross-linker; this support was then used to separate a racemic mixture 
of phenylalanine [583]. Another MIP based on a monolithic column and 
using 4-vinylpyridine as the functional monomer, ketoprofen as the tem-
plate, and ethylene glycol dimethacrylate as the cross-linking agent, was 
used for the chiral separation of ketoprofen [587]. 
5.4 Biointeraction Studies 
Affinity chromatography can also be employed as a tool for biophysical 
applications such as studies of solute–ligand interactions. In this tech-
nique, useful information on equilibrium and rate constants, and the 
number and types of affinity sites, can be obtained [11, 13, 14, 16]. Ad-
vantages of using this approach in such a way, especially when carried 
out on an HPLC system, are the speed, precision, and ease of automation 
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that can be obtained [14]. Methods that have been used for this purpose, 
as discussed in this section, are zonal elution, frontal analysis, and var-
ious techniques for kinetic studies [13, 14, 16].  
5.4.1 Zonal Elution Methods 
Zonal elution is an approach that has frequently been used in affinity 
chromatography to characterize the strength of solute–ligand interac-
tions [3, 11, 46]. In this approach, a small volume of an analyte or probe 
compound is introduced into an affinity column that contains an immo-
bilized ligand [11, 46]. The mobile phase used for the elution of the ana-
lyte or probe often contains a possible competing agent that is present at 
a known concentration; the pH, ionic strength, polarity, or temperature 
of the mobile phase may also be altered, as desired [11, 46, 591, 592]. 
Based on the retention time that is observed for the injected compound 
and the void volume of the column, the binding strength and type of in-
teractions that are present on the affinity ligand for the injected ana-
lyte/probe and competing agent can be determined [3, 11, 46, 591, 592]. 
Besides being used to examine interactions of solutes with native 
serum proteins, zonal elution has been utilized in recent reports to 
study the interactions of drugs with modified forms of proteins such as 
HSA and AGP [13, 162, 163, 592–597]. Zonal elution has also been em-
ployed with affinity columns for characterizing the interactions of Con 
A and AAL with AGP [48], the binding of protein G with rabbit IgG [137], 
and the binding of drugs such as acetaminophen and ketoprofen with 
β-cyclodextrin [310–313]. This method has also been used to investi-
gate the interactions of drugs or bioactive compounds with epidermal 
growth factor receptor, β2-adrenoceptor, and α1A-adrenoceptor in cell 
membrane chromatography [138, 598–601]. 
Various types of information that can be obtained from zonal elution 
experiments [11, 46, 591, 592]. This information can include the equi-
librium constant(s) for an interaction, the location of a given binding 
site (i.e., through the use of site-selective probes), and the type of com-
petition that is occurring between a given set of solutes for the bind-
ing agent. The effect of pH, solvent composition, and temperature on 
the binding strength and type of interaction that is present can also 
be examined by this approach [11, 46, 591, 592]. For example, zonal 
elution has been employed with affinity microcolumns to study the 
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effects of glycation on interactions of the sulfonylurea drug tolaza-
mide with HSA [134]. In another study, a zonal elution format was 
used with an anti-AGP column and adsorbed samples of AGP to look at 
the changes in binding by various drugs with purified or normal AGP 
and AGP from patients with lupus [593]. Zonal elution was also used 
in a recent report to examine the competition between folic acid and 
5-aminosalicylate for HSA [602]. 
5.4.2 Frontal Analysis Methods 
Frontal analysis is another affinity chromatography technique that is 
employed to study solute–ligand interactions [3, 11, 46, 260, 592]. The 
most common way of carrying out frontal analysis is by using a series 
of analyte solutions that are applied separately to a column, and with a 
washing step being used after each solution [3, 11, 46, 592]. In this for-
mat, the column is first equilibrated with the application buffer, with a 
known concentration of the target then being passed through the affin-
ity column until a breakthrough curve is formed. The retained target is 
next washed from  the column and this process is repeated using an-
other application of the target at the same or different concentration 
[3, 11, 46, 592]. If relatively fast association and dissociation are occur-
ring between the target and affinity ligand during the timescale of this 
experiment, the central position of the breakthrough curves can be re-
lated to the corresponding concentrations of the applied target to pro-
duce a binding isotherm. This isotherm is then fitted to one or more 
binding models to obtain the equilibrium constants and moles of bind-
ing sites that the immobilized binding agent and column have for the 
target [3, 11, 46, 592]. 
A relatively wide range of targets and binding agents has been exam-
ined in recent reports by affinity chromatography and the traditional 
form of frontal analysis [603–624]. Many of these studies have involved 
the analysis of binding by drugs or solutes with serum proteins such as 
HSA and AGP [3, 15, 162, 163, 592, 593, 596, 602, 603]. This approach 
has been used for studying the interactions of drugs with membrane pro-
tein and nuclear receptors, including voltage-dependent anion channel 1, 
G-protein-coupled receptors such as GPR17, nicotinic acetylcholine re-
ceptors, P-glycoproteins, β2-adrenergic receptors, dopamine receptors, 
and angiotensin-converting enzyme 2 receptors [330–332, 334–336, 
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604–610]. Antibody–antigen binding [616, 617] and fucose-specific lec-
tin-fucosylated glycan interactions [618] have been examined by frontal 
analysis using affinity columns. Additional systems that have been char-
acterized by affinity chromatography and frontal analysis span from the 
binding of boronates with cis-diol compounds [611, 612] to the binding 
of thrombin with phenolic acids [613] and the interactions of β2-agonists 
with MIPs [614]. Frontal analysis has also been used to determine the 
complexation stability constant and total moles of binding sites for Cu2+ 
ions with regards to l-glutamic acid [615]. 
Another format that has been explored for frontal analysis is the 
stepwise application of target solutions to an affinity column [260, 
619–621]. In this technique, the column is again first equilibrated with 
the application buffer with no target present. This is followed by the 
continuous application of the target in solutions going from a low to 
high concentration, producing a continuous breakthrough curve where 
a plateau is reached for each concentration and step in this process 
[260, 619–621]. Because this process is continuous and does not re-
quire washing steps in between the applied solutions of the target, 
it can require less of the target than traditional frontal analysis. This 
last feature has made this method attractive for use in cell membrane 
chromatography [619, 620]. For example, stepwise frontal analysis has 
been employed to obtain a dissociation equilibrium constant for the 
interaction of α1A adrenergic receptor with natural products and drugs 
such as dehydroevodiamine, tamsulosin, silodosin, oxymetazoline, and 
schizandrin A [601, 619, 620]. 
Frontal affinity chromatography coupled to mass spectrometry (FAC-
MS) has become an important tool for the high throughput screening of 
drug candidates against immobilized membrane receptor protein tar-
gets [331, 607, 622–624]. In this technique, the breakthrough curve for 
an applied target is followed by MS as the target interacts with an im-
mobilized binding agent [331, 607, 622–624]. There are two modes in 
which FAC-MS may be employed: the indicator mode and Q1 scan mode 
[331, 607, 622–624]. The indicator mode is based on how the presence 
of a competitor in the mobile phase causes a shift in the binding of an 
applied target with  the immobilized binding agent [607]. For instance, 
FAC-MS has been used with adsorption energy distribution calculations 
to study the adsorption of salbutamol on β2-adrenogenric receptor that 
was immobilized on polystyrene amino microspheres [607]. The shift 
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seen in this breakthrough curve for salbutamol was then examined in 
the presence of mobile phases that contained competing agents such as 
paeoniflorin, liquiritin, and a mixture of six compounds to see if FAC-MS 
could be employed for screening of site-specific bioactive chemicals in a 
complex matrix [607]. The second mode in which FAC-MS can be used 
is the Q1 mode. In this mode, multiple targets are screened simultane-
ously against a given binding agent and are ranked based on their af-
finity for this binding agent when it is used as a stationary phase [331, 
624]. This mode has been employed for the screening of ligands against 
human estrogen receptor β and a G-protein coupled receptor [331, 624]. 
5.4.3 Methods for Kinetic Studies 
Affinity chromatography has been used to study the kinetics of various 
solute–ligand interactions [16, 625–627]. The most common format for 
this work is to examine the retention or peak shape that is obtained for 
a target that is applied or injected onto an affinity column that contains 
an immobilized form of the desired binding agent [16, 625–627]. Exam-
ples of techniques for kinetic studies that make use of this general for-
mat include those that use band-broadening measurements (e.g., the 
plate height and peak profiling methods) [202, 310, 311, 313, 628–632], 
peak decay analysis [137, 633–635], the split-peak effect [636–638], and 
peak fitting [598, 632, 639–641]. 
The plate height method and related technique of peak profiling for 
kinetic analysis both make use of band-broadening measurements [202, 
310, 311, 313, 628–632]. These methods are based on the application of 
a small volume of a target under linear elution conditions onto an affin-
ity column and control column at one or several flow rates; the degree 
of band-broadening is then compared on these two types of columns to 
obtain the contribution due to stationary phase mass transfer. This value, 
in turn, can be used with the known flow rate and measured retention 
factor for the target on the affinity column to determine the dissocia-
tion rate constant for this interaction process [628, 629]. Peak profiling 
has been utilized to examine the interactions of various drugs with the 
serum proteins AGP and HSA [262, 630, 631] and with β-cyclodextrin 
[310, 311, 313]. This method has further been used to examine the in-
teractions of membrane receptors with drugs and bioactive compounds 
[242, 632].
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Peak decay is another method that can be employed for kinetic anal-
ysis in affinity chromatography [137, 633–635, 641]. This method in-
volves the application of a target solute onto both an affinity column and 
control column in the presence of high flow rates and/or mobile phase 
conditions that prevent rebinding of the target as it is dissociated for an 
immobilized binding agent. This method can be performed in both com-
petitive and non-competitive formats, depending on whether a compet-
ing agent is added to the mobile phase to promote target release and to 
avoid rebinding to the affinity column [137, 633–635, 641]. Peak decay 
has been employed with affinity chromatography for the analysis of var-
ious systems. Examples include studies of drug dissociation from serum 
proteins such as HSA and AGP [633–635], work examining antibody–an-
tigen interactions [137], and studies of the interactions of β2-adrenergic 
receptor with a number of drugs [641].
Another kinetic technique that employs an immobilized binding 
agent is the split-peak method. The split-peak method makes use of 
conditions in which a target binds irreversibly to the affinity ligand but, 
due to the short time allowed for this binding, a small fraction of the 
target also passes through the column as a non-retained peak [636–
638]. The relative amount of target that is in the free vs. retained frac-
tions at various flow rates can be used to obtain information on the 
association rate constant for the target with the immobilized binding 
agent or on the rate of stagnant mobile phase mass transfer in the col-
umn [633–635, 641]. This technique has been used to study antibody–
antigen interactions and the binding of protein A and protein G with 
immunoglobulins [636–638].
The peak fitting method is performed by injecting various concentra-
tions of a target onto an affinity column and looking at the retention and 
shape of the resulting peak as the sample concentration is varied [598, 
632, 639–641]. By fitting these peaks to various models, it is possible 
to obtain the rate constants for interactions by the target with the affin-
ity ligands. Peak fitting has been used in both zonal elution and frontal 
analysis formats for studying the interactions of drugs with immobilized 
receptors such as β2-adrenergic receptor and nicotinic acetylcholine 
receptor [598, 632, 639–642].
An alternative format for kinetic studies is to apply a small target in 
the presence of a soluble binding agent onto an affinity column which 
contains an immobilized binding agent for the target. This immobilized 
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binding agent may be the same as the soluble binding agent or a differ-
ent ligand, and acts as a secondary probe to extract the unbound frac-
tion of the solute from the sample [16, 139–142, 625–627, 643]. This 
technique is known as ultrafast affinity extraction. This method makes 
use of a short time for extraction of the target by employing medium-
to-high flow rates and small affinity columns. This approach has been 
used to provide information on both the thermodynamics and kinetics 
of the interactions between a number of drugs or hormones and serum 
transport proteins such as HSA, AGP, and sex hormone-binding globulin 
[139–142, 643]. Both single-column systems and two-column systems 
have recently been described for ultrafast affinity extraction, with the 
single-column system being used for kinetic studies [139–141]. 
6 Conclusions 
Affinity chromatography and related techniques based on supramolec-
ular interactions have continued to expand and be adapted as tools for 
achieving selective separations and in examining the components of 
complex samples. A few examples that were discussed in this review 
included improvements in natural, inorganic, and synthetic supports for 
affinity chromatography; the use of magnetic particles, smart materials, 
and nanomaterials as new supports for affinity methods; and the contin-
ued development of support formats based on capillaries, packed beds, 
monoliths, and microscale separations. In addition, advances and new 
approaches have appeared in  the development of new synthetic meth-
ods and tools, for covalent immobilization, biospecific adsorption, and 
non-covalent immobilization in affinity chromatography. 
The variety of biological and non-biological binding agents that may 
be employed as stationary phases in affinity separations has also shown 
continued growth and development. Biological agents that are now often 
employed in affinity separations range from enzymes, antibodies, immu-
noglobulin-binding proteins, serum proteins, and lectins to biotin com-
bined with avidin or streptavidin, carbohydrates, lipids, and nucleic acid-
based ligands, including aptamers. Advances and ongoing work have 
appeared as well in the use of non-biological ligands, such as methods 
that employ boronates, mixed ligands, dye-ligands, immobilized metal 
ion chelates, or MIPs. 
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These advances in the components of affinity chromatography have 
been associated with improved or expanded capabilities that allow this 
method to be used for a broad set of applications. Affinity chromatog-
raphy has remained an important separation method for the purifica-
tion of enzymes, native proteins, and recombinant proteins. However, 
this method has also grown as an approach that can be used to purify 
and characterize viral particles, cells, and related targets. Many ana-
lytical applications have continued to appear as well, such as the use 
of affinity separations for sample pretreatment, the removal of specific 
solutes from a sample (i.e., as part of immunoextraction or immunode-
pletion), and for the direct or indirect measurement of a particular tar-
get in a complex matrix (e.g., by means of chromatographic immunoas-
says). A related use of affinity chromatography for chemical purification 
or analysis has been in the field of chiral separations. Finally, affinity-re-
lated separations have seen further advances in approaches by which 
they can be used to study biological interactions by means such as zonal 
elution, frontal analysis, or various formats that can be employed for ki-
netic studies. Overall, the variety of system components and formats that 
may be used in affinity chromatography and related methods should 
continue in the future to make these techniques popular and powerful 
separation and analysis tools in fields such as analytical chemistry, bio-
chemistry, clinical testing, environmental analysis, molecular biology, 
and pharmaceutical science. 
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